Podcast
Breaking Barriers in Weight Management for Your Patients with T2D
Array
Activity Info
Primary care providers are in a unique position to address both diabetes and weight management in the same patient at the same time, partially through judicious choice of medication that has beneficial effects on both HbA1c and weight. Three short patient case modules address attitudes and beliefs that may be barriers to optimal weight management for patients with T2D.
| Activity Title: | Advancing Clinical Practice: Breaking Barriers in Weight Management for Your Patients With T2D |
| Topic: | Type II Diabetes |
| Accreditation Type: |
|
| Accreditor: | The France Foundation |
| Release Date: | June 14, 2024 |
| Expiration Date: | June 13, 2025 |
| Estimated Time to Complete Activity: | 1.5 hours |
TARGET AUDIENCE
This educational activity is intended for healthcare providers (HCPs) who treat patients with type 2 diabetes (T2D) in the primary care setting. Specifically, members of the primary care team, including physicians, nurse practitioners (NPs), PAs, and other members of the health care team who treat patients with T2D.
PROGRAM OVERVIEW
Primary care providers are in a unique position to address both diabetes and weight management in the same patient at the same time, partially through judicious choice of medication that has beneficial effects on both HbA1c and weight. Three short patient case modules address attitudes and beliefs that may be barriers to optimal weight management for patients with T2D.
LEARNING OBJECTIVES
Through the application of the strategies, tools, and resources shared in this education, learners will demonstrate improvements in their confidence, knowledge, and skills to:
- Identify common attitudes and beliefs that are barriers to optimal weight management for patients with T2D
- Utilize current research and guideline recommendations to modify treatment plans to optimize weight management for patients with T2D
- Integrate strategies for weight-management planning into shared decision-making discussions with patients with T2D
FACULTY
Alan Schwartz, PhD, JD
Education Research Professor
UIC Department of Pediatrics
Ankush Bansal, MD
Internal Medicine Hospitalist
Practices via Telemed
Jason Lofton, MD
Family Medicine Specialist
Lofton Family Clinic
Nicholas Pennings, DO, FOMA, FACOFP
Chair and Associate Professor of Family Medicine
Jerry M. Wallace School of Osteopathic Medicine
Campbell University
Paul Doghramji, MD, FAAFP
Family Practice Physician
Collegeville Family Practice
Samantha Flanagan, DO
Assistant Professor of Clinical Family and Community Medicine
Lewis Katz School of Medicine
Temple University
Silvana Pannain, MD
Associate Professor of Medicine, Endocrinology, Diabetes, and Metabolism
Obesity Medicine Director, Center for Weight and Metabolic Health
Director of Chicago Weight, A Comprehensive Obesity Medicine Program
University of Chicago Medicine
PLANNING COMMITTEE
Alan Schwartz, PhD, JD
Education Research Professor
UIC Department of Pediatrics
Nicholas Pennings, DO, FOMA, FACOFP (Chair)
Chair and Associate Professor of Family Medicine
Jerry M. Wallace School of Osteopathic Medicine
Campbell University
Samantha Flanagan, DO
Assistant Professor of Clinical Family and Community Medicine
Lewis Katz School of Medicine
Temple University
Silvana Pannain, MD
Associate Professor of Medicine, Endocrinology, Diabetes, and Metabolism
Obesity Medicine Director, Center for Weight and Metabolic Health
Director of Chicago Weight, A Comprehensive Obesity Medicine Program
University of Chicago Medicine
INSTRUCTIONS FOR PARTICIPATION AND REQUESTING CREDIT
There are no fees for participating and receiving credit for this activity. Successful completion is achieved by reviewing the CE information, completing the pre-test, completing the activity, and completing the post-test and evaluation form. A score of at least 75% on the posttest is required to successfully complete this activity. The participant may take the test until successfully passed.
Credit fulfillment
- If you are requesting AMA credits, ANCC credits, AAPA credits, or a certificate of participation, your certificate will be available for download
Technical Requirements
This site and its activities are best viewed using the latest versions of the Chrome, Edge, Firefox, and Safari browsers. Additionally, this site and its activities are best viewed using the latest operating system for your device.
ACCREDITED PROVIDER
This activity is jointly provided by The France Foundation and ArcheMedX.
ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by The France Foundation and ArcheMedX. The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION
Physicians
The France Foundation designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
The France Foundation designates this activity for 1.5 contact hours.
Physician Assistants
The France Foundation has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid until June 13, 2025. PAs should only claim credit commensurate with the extent of their participation.
All other healthcare professionals completing this course will be issued a statement of participation.
DISCLOSURE POLICY
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, The France Foundation (TFF) and ArcheMedX require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial entity. TFF and ArcheMedX resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs.
Furthermore, TFF and ArcheMedX seek to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF and ArcheMedX are committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.
Planning committee members, faculty, reviewers, and activity staff have disclosed the following relevant financial relationships. All relevant financial relationships listed have been mitigated.
Name of Individual
Role in Activity
Name of Commercial Interest(s)
Nature of Relationship(s)
Mechanism(s) Implemented to Resolve Conflict of Interest
Alan Schwartz, PhD, JD
Planning Committee; Faculty
1. Laguna Health
1. Non-CE Consulting
All final planning decisions concerning content, learning objectives, and evaluation questions were made by the non-conflicted Planning Committee Chair
Content was reviewed by a non-conflicted member of the planning committee to ensure that it is not commercially biased, was fair-balanced, and is based on scientific evidence and/or clinical reasoning
Content was reviewed by a non-conflicted member of the planning committee to ensure that it is not commercially biased, was fair-balanced, and is based on scientific evidence and/or clinical reasoning
Amanda Noe
TFF Staff
No relevant financial disclosures
NA
NA
Ankush Bansal, MD
Faculty
No relevant financial disclosures
NA
NA
Ashley Smeaton
TFF Staff
No relevant financial disclosures
NA
NA
Jason Lofton, MD
Faculty
No relevant financial disclosures
NA
NA
Jaspreet Chahal, MS
TFF Staff
No relevant financial disclosures
NA
NA
Kylie Bleau
Collaborator
No relevant financial disclosures
NA
NA
Kenny Cox, CHCP, FACEHP
Collaborator
No relevant financial disclosures
NA
NA
Margaret Das, PhD
TFF Content Reviewer
No relevant financial disclosures
NA
NA
Nicholas Pennings, DO
Planning Committee Chair, Faculty
1. Abbott
2. Medifast
2. Medifast
1. Non-CE Consulting
2. Independent Contractor
2. Independent Contractor
All final planning decisions concerning content, learning objectives, and evaluation questions were made by the non-conflicted Planning Committee Chair
Content was reviewed by a non-conflicted member of the planning committee to ensure that it is not commercially biased, was fair-balanced, and is based on scientific evidence and/or clinical reasoning
Content was reviewed by a non-conflicted member of the planning committee to ensure that it is not commercially biased, was fair-balanced, and is based on scientific evidence and/or clinical reasoning
Paul Doghramji, MD, FAAFP
Faculty
1. Bayer, J&J
2. Abbvie, Amgen, AstraZeneca, Axsome, Idorsia
2. Abbvie, Amgen, AstraZeneca, Axsome, Idorsia
1. Non-CE Consulting
2. Non-CE Speakers Bureau
2. Non-CE Speakers Bureau
Content was reviewed by a non-conflicted member of the planning committee to ensure that it is not commercially biased, was fair-balanced, and is based on scientific evidence and/or clinical reasoning
Samantha Flanagan, DO
Planning Committee; Faculty
No relevant financial disclosures
NA
NA
Silvana Pannain, MD
Planning Committee; Faculty
1. Ei Lilly, Novo Nordisk
2. Amgen
3. Ei Lilly
2. Amgen
3. Ei Lilly
1. Non-CE Consulting; Non-CE Speakers Bureau
2. Contract Research
3. Owns stock in publicly held ineligible company
2. Contract Research
3. Owns stock in publicly held ineligible company
All final planning decisions concerning content, learning objectives, and evaluation questions were made by the non-conflicted Planning Committee Chair
Content was reviewed by a non-conflicted member of the planning committee to ensure that it is not commercially biased, was fair-balanced, and is based on scientific evidence and/or clinical reasoning
Content was reviewed by a non-conflicted member of the planning committee to ensure that it is not commercially biased, was fair-balanced, and is based on scientific evidence and/or clinical reasoning
Disclosure of Unlabeled Use:
TFF and ArcheMedX require CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that are outside of US Food and Drug Administration approved labeling.
This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF and ArcheMedX do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.
COMMERCIAL SUPPORT ACKNOWLEDGMENT
This activity is supported by an independent medical educational grant from Lilly.
Disclaimer
The France Foundation and ArcheMedX present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately based on their own clinical judgment and accepted standards of care. The France Foundation, ArcheMedX, and the commercial supporter(s) assume no liability for the information herein.
COPYRIGHT INFORMATION
Copyright © 2024 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:
- The materials are to be used solely for personal, noncommercial, informational, and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
- Materials may not be published, uploaded, posted, or transmitted (other than as set forth herein) without The France Foundation's prior written permission
PRIVACY POLICY
The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except when such information is required for reporting purposes to the ACCME.
The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of information that we have collected from you.
Additional information regarding The France Foundation’s Privacy Policy can be viewed at https://www.francefoundation.com/privacy.
CONTACT INFORMATION
If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or info@francefoundation.com.
